Results 221 to 230 of about 154,650 (346)

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

open access: yesHepatology, 2003
G. Marchesini   +10 more
semanticscholar   +1 more source

Protective Effect of Epigallocatechin‐3‐Gallate Against Fructose‐Induced Metabolic Associated Fatty Liver Disease in Mice by Regulating Ferroptosis and Autophagy via SIRT5

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Metabolic dysfunction‐associated fatty liver disease (MAFLD) lacks effective pharmacological therapies and is strongly associated with excessive fructose consumption. Ferroptosis and autophagy dysregulation are increasingly recognized as key drivers of MAFLD progression.
Puyu Zhang   +11 more
wiley   +1 more source

Magnoflorine Ameliorates MASH in Mice Fed a High‐Fat and High‐Fructose Diet by Promoting AMPK‐Mediated Lipophagy and Fatty Acid Oxidation

open access: yesPhytotherapy Research, EarlyView.
Magnoflorine ameliorates metabolic dysfunction‐associated steatohepatitis by promoting AMPKα‐mediated lipophagy and fatty acid oxidation. ABSTRACT Emerging as a significant clinical burden, metabolic dysfunction‐associated steatohepatitis (MASH) continues to challenge global healthcare systems due to limited effective interventions.
Zhengjie Lu   +6 more
wiley   +1 more source

Polyphyllin I Alleviates Alcoholic Liver Disease via Modulation of the Phosphodiesterase 6D–Cyclic Guanosine Monophosphate–Protein Kinase G Axis

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Alcoholic liver disease (ALD) is a multifaceted disorder in which oxidative injury, iron‐dependent ferroptosis, steatosis, and inflammation are closely intertwined. Consequently, therapeutic strategies targeting a single pathway often produce limited clinical benefits.
Hongyan Feng   +7 more
wiley   +1 more source

Limited impact of NLRP3 inflammasome deficiency on diet-induced metabolic dysfunction-associated steatohepatitis in mice. [PDF]

open access: yesBiochem Biophys Rep
Taguchi D   +7 more
europepmc   +1 more source

Propolis Supplementation in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesPhytotherapy Research, EarlyView.
In this systematic review and meta‐analysis of four randomized controlled trials (n = 178) of Iranian propolis in adults with MASLD, propolis supplementation was associated with improvement in ultrasound‐assessed hepatic steatosis (three trials, n = 156; RR 2.41, 95% CI 1.59–3.66) and a modest reduction in fasting glucose, with no significant effects ...
Ting‐An Kuo   +4 more
wiley   +1 more source

HSPE1 deficiency underlies the crosstalk between metabolic dysfunction‐associated steatotic liver disease and age‐related macular degeneration

open access: yesVIEW, EarlyView.
Rare‐earth ions act as multifunctional modifiers in perovskite solar cells by improving charge transport, suppressing oxygen vacancies, passivating defects, promoting grain growth, and enabling redox‐mediated stabilization. In addition, RE‐doped layers can expand spectral utilization through upconversion and downconversion, thereby enhancing light ...
Jiaqi Meng   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy